TP53 and neoplasm: Our previous study showed that the tumor-specific miR-26a overexpression, driven by a hAFP–TERT dual promoter, decreased the viability of tumor cells in HCC by regulating the expression of the estrogen receptor (ER)-α, progesterone receptor (PR), p53, cyclin D2, and E2 [12].